cardiovascular disease
cardiovascular disease
Roche’s $50B US Boost: Jobs and Growth Ahead!
BIOT
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Revolutionary Stem Cell Therapy for Heart Disease!
BIOT
🚀 Cellino & Karis Bio unite for personalized iPSC therapies! 🩺 Aiming to transform cardiovascular treatment with innovative stem cell solutions. 🌏🔬
